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Abstract
The objective of this critical review is to provide an overview of how emerging bioanalytical techniques are expanding our
understanding of the complex physicochemical nature of virus interactions with host cell surfaces. Herein, selected model viruses
representing both non-enveloped (simian virus 40 and human norovirus) and enveloped (influenza A virus, human herpes
simplex virus, and human immunodeficiency virus type 1) viruses are highlighted. The technologies covered utilize a wide
range of cell membrane mimics, from supported lipid bilayers (SLBs) containing a single purified host membrane component to
SLBs derived from the plasma membrane of a target cell, which can be compared with live-cell experiments to better understand
the role of individual interaction pairs in virus attachment and entry. These platforms are used to quantify binding strengths,
residence times, diffusion characteristics, and binding kinetics down to the single virus particle and single receptor, and even to
provide assessments of multivalent interactions. The technologies covered herein are surface plasmon resonance (SPR), quartz
crystal microbalance with dissipation (QCM-D), dynamic force spectroscopy (DFS), total internal reflection fluorescence (TIRF)
microscopy combined with equilibrium fluctuation analysis (EFA) and single particle tracking (SPT), and finally confocal
microscopy using multi-labeling techniques to visualize entry of individual virus particles in live cells. Considering the growing
scientific and societal needs for untangling, and interfering with, the complex mechanisms of virus binding and entry, we hope
that this review will stimulate the community to implement these emerging tools and strategies in conjunction with more
traditional methods. The gained knowledge will not only contribute to a better understanding of the virus biology, but may also
facilitate the design of effective inhibitors to block virus entry.
Keywords Virus protein to host membrane interactions . Quartz crystal microbalance with dissipation . Dynamic force
spectroscopy . Total internal reflection fluorescencemicroscopy . Equilibrium fluctuation analysis . Single particle tracking
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Introduction
Viruses are obligate intracellular parasites requiring access to
the intracellular environment in order to replicate. Binding of
the virus particle to the plasma membrane of the target cell is
an important first step in the viral replication process. It is
mediated by specific receptors and attachment factors [1].
While attachment factors are only involved in the attachment
of the virus particles to the cell surface, cellular receptors
promote the entry of the virus. Many viruses exploit several
attachment factors, co-receptors and receptors that are typical-
ly engaged in series and/or in parallel via complex kinetic
pathways. It is experimentally demanding to demonstrate true
receptor status and thus, binding entities have often been
reconsidered from being attachment factors to being receptors,
as their roles in entry have become clarified. Some viral re-
ceptors have endocytic functions, such as transferrin and low-
density lipoprotein receptors, while others exhibit alternative
transport functions or are involved in binding to the extracel-
lular matrix [2], illustrating how a variety of recognition
events can be hijacked by viruses when entering cells. Even
though the attachment factors are not directly involved in the
entry of the virus into the cell, they are important for initiation
of infection [1]. They have been suggested to concentrate and
orient the virus near the cell surface and to allow the virus
particles to get in close contact with their membrane-bound
receptors, adding to the molecular and spatiotemporal com-
plexity of the process. The presence of attachment factors and
receptors is also a major determinant of the tropism of viruses,
i.e., the selective ability to infect only specific species, tissues,
and cell types [1]. The tropism of a virus thus determines the
pathogenesis of the disease and defines the mechanisms of
transmission [3].
Although the virus uptake mechanisms are principally sim-
ilar across viral species, the molecular details are specific for
each virus/target cell combination. Viruses are not passive
cargoes, but trigger internalization by activating endocytic
processes. This can be done by activating signaling pathways
through direct or indirect contacts with cell-surface molecules
and structures, including triggering of clathrin coat formation
[3]. Different endocytic mechanisms including clathrin-
dependent and clathrin-independent endocytosis and
macropinocytosis have been reported for viral entry [2].
Moreover, even for one type of virus, there may be multiple
pathways leading to productive viral replication. In addition to
binding and entry, the passage of the virus particle, or at least
of the viral genome, through a membrane into the cytosolic
environment is a critical step in viral entry. This process is
called penetration and often occurs in the endosome
(endosomal escape). While non-enveloped viruses penetrate
the endosomal membrane by membrane lysis or by pore for-
mation, enveloped viruses fuse their membrane with the cel-
lular membrane [3]. The penetration is activated by cellular
cues, for instance a pH decrease through the endosomal sys-
tem. Fusion of enveloped viruses is typically primed as a
conformational change of a fusion protein in a process which
frees a hydrophobic part of the protein, the fusion peptide.
This is followed by insertion of the fusion peptide into the
host cell membrane pulling the viral membrane and cellular
membrane closer together [4–6]. This leads first to
hemifusion, i.e., lipid exchange between the proximal mem-
brane leaflets, followed by the complete fusion of both leaflets
of the two membranes, resulting in the formation of a fusion
pore and release of the viral genome into the cytosol.
It is worth noting that individual virus-receptor interactions
at the cellular membrane are typically weak and provide only
short residence times. Virus binding therefore usually in-
volves the parallel engagement of many such interactions,
thereby forming so-called multivalent interactions [7]. Such
low affinity interactions are frequently mediated by
glycoconjugates in the forms of glycoproteins and
glycosphingolipids (GSLs), the glycan often being crucial
for the interaction [8–10]. These glycoconjugates commonly
function as receptors, but many viruses also take advantage of
them as attachment factors, as is the case for negatively
charged sialylated glycans or glycosaminoglycans such as
heparan sulfate [11]. Such interactions can be primarily elec-
trostatic in nature, and thus rather unspecific, but not seldomly
also highly specific. Due to an exponential dependence be-
tween residence time and the strength of the interaction, the
number of receptors bound by the virus (the valency of the
interaction), has a much stronger than linear dependence on
residence time of the virus, as manifested in non-trivial depen-
dencies between receptor concentration and virus binding rate,
also called superselectivity [7, 12, 13]. Multivalency is critical
for appropriate attachment of viruses, both in terms of attach-
ment strength and residence time, both of which are essential
to commence cellular uptake or entry of the bound viruses.
Furthermore, multivalency does not only prolong and
strengthen the interaction between the virus particle and the
host cell, but also provides the basis for mechanisms that are
not available in monovalent systems [7]. For instance,
multivalency provides opportunities to control the movement
of virus particles on the cell surface as the lateral diffusion of a
bound virus particle decreases with the number of interaction
points. Importantly, multivalency also facilitates reorganiza-
tion of the membrane. For example, the multivalent binding of
GSL receptors has been shown to induce formation of mem-
brane invaginations that are scissioned into endocytic vesicles
transporting the virus to the endosome [14].
Due to the importance of virus-receptor interactions for
viral entry, virologists, chemical biologists, biochemists, and
biophysicists alike have all shown great interest in untangling
the complex mechanisms governing receptor-mediated viral
uptake. Such knowledge does not only contribute to a better
understanding of infection biology, but may also facilitate the
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design of effective inhibitors to block viral entry pathway(s).
Such insights are urgently needed not only to combat existing
viral diseases, but also to rapidly react against emerging viral
pathogens, such as the severe acute respiratory syndrome co-
ronavirus 2 (SARS-CoV-2). This review focuses on selected
key biomolecular processes mediating virus attachment and
entry, all relying on the dynamic molecular interactions be-
tween viral proteins and cell-surface molecules. In particular,
it highlights how recent methodological developments can
contribute to a deeper understanding of such dynamic interac-
tions. It further illustrates and discusses how such knowledge
can contribute to the development of antiviral drugs targeting
viral adhesion proteins, cellular receptors/attachment factors,
their interactions, or factors essential in driving such
interactions.
Model viruses
To reflect the diversity of virus binding and entry as well as
the need for different methodological approaches to study
such processes, we have selected a few well-characterized
non-enveloped (simian virus 40 and norovirus) and enveloped
(influenza A virus, herpes simplex virus-1, and human
immunodeficiency virus type 1) model viruses. Basic charac-
teristics of these viruses are summarized below and in Table 1.
Simian virus 40
Simian virus 40 (SV40) belongs to the Polyomaviridae and is a
non-enveloped DNA virus (Table 1). The SV40 capsid has a
diameter of ~ 45 nm and its external surface is composed of
360 copies of the VP1 protein organized into pentamers. Each
VP1 protein has one binding site for the α2,3-sialylated GSL
GM1 [15], which is the cellular receptor for the virus [14, 16].
The affinity of the capsid is higher to the sialic acid variant
Neu5Gc than to Neu5Ac [17]. Humans lack expression of
Neu5Gc because of an inactivating mutation in the gene coding
for the rate-limiting enzyme in Neu5Gc biosynthesis [18]. This is
one of the reasons why SV40 infects human cells less efficiently
than cells from monkeys, the natural host of the virus [17], and
accordingly, the virus is not an important human pathogen [19].
Nevertheless, it is included in this review since it has beenwidely
studied as a model virus thereby contributing to the understand-
ing of viral entry and viral DNA synthesis.
Norovirus
Norovirus is a non-enveloped positive-sense single-stranded
RNA virus (Table 1). It belongs to the Caliciviridae and is
divided into ten genogroups (G), of which GI, GII, and GIV
infect humans [20]. The virus has a diameter of ~ 40 nm and is
made up of an icosahedral capsid built of 90 dimers of the
major capsid protein VP1 [21]. Despite intense efforts, the
receptor of the human norovirus remains unknown, but sus-
ceptibility to infection requires expression of specific ABO(H)
and Lewis histo-blood group antigens (HBGAs), which are
recognized by the virus in a strain-dependent manner [22].
Most strains bind to the α1,2-fucosylated glycans of the
HBGA family and individuals of the so-called non-secretor
type, which lack expression of these glycans on the mucosal
epithelia, have been shown to be resistant to such strains. The
HBGAs are found both on glycoproteins and on
glycosphingolipids [23]. In addition, human norovirus has
been shown to bind to heparan sulfate [24], to sialylated gly-
cans including SLex [25] and gangliosides [26], as well as to
the GSL galactosylceramide [27]. Norovirus is included in
this review because of its binding to HBGAs, which has been
thoroughly investigated in a number of lipid-membrane-based
assays. The fact that the virus binds to several structurally
closely related glycans has allowed for interesting compari-
sons that have unraveled the detailed characteristics of virus
attachment and detachment to membrane-bound GSLs.
Finally, the interaction with HBGAs has been shown to be
critical for norovirus infection as the expression of these gly-
cans determines susceptibility to the infection [22, 23].
Influenza A virus
Influenza A virus belongs to theOrthomyxoviridae family and
is a negative-sense RNA virus with the genome divided into
eight segments (Table 1). The virus particle is enveloped and
has a cross sectional diameter of ~ 100 nm. The length of the
particle, however, may differ substantially from this number,
when appearing in spherical, elliptical and even filamentous
shapes, depending on the IAV strain. The receptor of the virus
was early suggested to contain sialic acid, but despite inten-
sive studies, it is still not known whether the receptor is found
on a glycoprotein or on a GSL [28]. Interestingly, strains of
human influenza A virus prefer to bind to sialic acid with an
α2,6-linkage to galactose while strains of avian influenza A
prefer α2,3-linked sialic acid [9, 28, 29], which limits the
spread between species. The binding to sialic acid is mainly
mediated by the hemagglutinin (Hn) protein, which in addition
is also responsible for the pH-induced fusion of the viral en-
velope with the endosomal membrane of the target cell. In
addition to the hemagglutinin, the viral membrane also con-
tains a neuraminidase (Nn), which binds to, and cleaves off,
sialic acids from the cellular receptors. The balance of these
two viral activities is considered critical for the whole infec-
tious process [30, 31]. Recently, it was found that several
influenza A viruses also bind to phosphorylated, non
sialylated N-glycans, present in the human lung, which may
explain why desialylation with neuraminidase does not block
infection [32]. Influenza A virus is included in this review
because of its well-characterized interaction with sialylated
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Table 1 Characteristics of model viruses used to illustrate various concepts for virus-host interactions
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glycans, which has been studied with a large array of
bio(physico)chemical approaches ranging from ensemble av-
eraging methods, to high-resolution optical microscopy to
atomic force spectroscopy. Such investigations of this virus
led to the first demonstration that off-rates (desorption or un-
binding rate) can be extracted from studies of single virus
particle binding to membranes.
Herpes simplex virus type 1
Herpes simplex virus type 1 (HSV-1) is an enveloped DNA
virus belonging to the Herpesviridae family (Table 1) [33,
34]. The particle has a diameter of 170–200 nm [34] and
contains 15 proteins, of which the 4 glycoproteins gD, gH,
gL, and gB are considered necessary for cell entry [35]. HSV-
1 uses heparan sulfate as the attachment factor and the inter-
action is mediated by gB together with gC. The three host
factors nectin-1, herpes virus entry mediator (HVEM), and
3-O-sulfated-heparan sulfate can function as receptors for
the virus, either alone or in combination. The binding of one
of these receptors triggers a conformational change in gD,
which thereafter interacts with the viral heterodimer of gH/
gL. This interaction in turn causes an activation of gB, which
is the protein that mediates the fusion with the cell membrane.
The virus seems to enter different types of cells by different
mechanisms [35]; it has been suggested that it enters epithelial
cells by endocytosis and neural cells by fusion at the plasma
membrane [35]. HSV-1 is included in this review as an exam-
ple of a glycosaminoglycan-binding virus. Importantly, stud-
ies of HSV-1 have shown that the strength of the binding to
glycosaminoglycans determines the diffusion of the virus par-
ticle on the plasma membrane and that proteoglycans have the
potential to be functional receptors.
Human immunodeficiency virus type 1
Human immunodeficiency virus type 1 (HIV-1) belongs to the
Retroviridae family (Table 1). The virus particle is enveloped
Fig. 1 Virus binding to cell membranes is a complex and highly dynamic
process. (A) Viruses are known to present multiple copies of proteins (e.g.,
VP1 in the polyomavirus SV40) that are able to bind to receptors or attach-
ment factors (AFs) presented by the cell’s plasma membrane. In order to
achieve firm attachment to cell membranes, viruses typically have to bind
many receptors/attachment factors in parallel, which leads to a very dynamic
and complex binding process. The understanding of this process requires
precise knowledge on the properties of the constituents (e.g., the mobility D
of receptors/attachment factors in themembrane, the rate constants kon and koff
of the molecular interaction between single viral proteins and their receptors/
attachment factors) and the underlying biophysical laws, which can be ob-
tained using biochemical and biophysical techniques (some of which are
discussed in this review), but often requires to approximate the native situa-
tion by simplified model systems (e.g., by approximating virus-cell interac-
tions by the interaction of virus-like particleswith less complex lipid bilayers).
Such investigations have, for example, enabled to generate a numericalmodel
of SV40 that allows to study the impact of receptor concentration, mobility,
and binding strength (A, lower panel) on the dynamics of virus attachment
and the motion of membrane-bound viruses (B). Adapted with permission
from [42]
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and has a diameter of ~ 125 nm [36]. HIV-1 has a positive
single-stranded RNA genome that is converted to DNA in in-
fected cells by the viral reverse transcriptase before being inte-
grated into the host genome. HIV-1 primarily infects immune
cells which express the viral receptors and the primary receptor
of the virus is the cluster of differentiation 4 (CD4) glycoprotein.
The interaction with this receptor leads to exposure of binding
sites allowing for interactions with chemokine receptors, i.e.,
CCR5 and/or CXCR4, which are co-receptors for the virus.
The viruses that mediate primary infections typically use
CCR5 as co-receptor, while viruses associated with late-stage
infections usually use CXCR4 [36]. Heparan sulfate,
galactosylceramide, mannose-binding lectin, and DC-SIGN
have all been identified as attachment factors for the virus [37].
The entry of the virus particle into the cell is usually considered
to bemediated by fusion at the plasmamembrane, but fusion can
also occur after endocytosis of the virions [36]. HIV-1 is includ-
ed in this review as an example of a virus using protein receptors
and because biophysical investigations have uniquely contribut-
ed to providing mechanistic details of the fusion process.
Methodological considerations
As virus-receptor interactions are of paramount importance
for virus attachment to target cell membranes and often drive
virus internalization, their characteristics have been the subject
of intense research. Amultitude of methods have been applied
in such studies, probing the interactions on different levels of
complexity (e.g., either employing the entire, membrane-
associated receptor complex, utilizing isolated ligand-
receptor pairs, or even focusing on specific protein domains
such as receptor binding domains) and providing quantitative
insights into the interactions. For example, isothermal titration
calorimetry (ITC) has been used to determine the heat released
by binding of attachment factors to viral proteins, yielding
information on dissociation constant Kd, the change in free
enthalpy (ΔH), and free energy (ΔG) associated with the
binding process [38, 39]. In these experiments, isolated virus
proteins and attachment factors are typically used, yielding
information on the monomeric interaction. Nuclear magnetic
resonance (NMR) spectroscopy measures changes of chemi-
cal shifts of residues involved in the binding process, thus
yielding the engagement of the viral proteins versus increasing
concentrations of attachment factors [40, 41]. These binding
curves typically possess a sigmoidal shape if plotted as func-
tion of the logarithm of the attachment factor concentration.
The inflection point of this curve corresponds to the Kd value
of the interaction, which is typically determined by non-linear
least squares fitting of a Langmuir-type binding isotherm to
the data. Such experiments have been done using both isolated
viral proteins and entire viruses, but are typically limited to the
use of truncated variants of the membrane receptor.
In principle, methods such as ITC and NMR can be used to
determine the monovalent binding affinity of viral proteins
interacting with water-soluble attachment factors. The overall
(multivalent) interaction of a virus with a cell membrane
shows, however, a very complex dependence on multiple pa-
rameters (Fig. 1), such as the monovalent binding affinity, the
valency, and the mobility of the receptors in the membrane,
and can, in principle, be further modified by steric hindrance
or (anti-)cooperativity effects [43, 44], causing the
(monovalent) binding affinity in a multivalent complex to
decrease or increase depending on the number of interactions
engaged. Quantifying the overall interaction avidity therefore
requires approaches able to probe the interaction of viruses
with receptors or attachment factors in a biomimetic environ-
ment, e.g., by embedding host membrane components in lipid
membranes (e.g., lipid-bound factors) or attaching them at
interfaces (e.g., for glycosaminoglycans). Such measurements
can be conducted using surface-sensitive techniques such as
quartz crystal microbalance with dissipation (QCM-D), sur-
face plasmon resonance (SPR) spectrometry, or biolayer in-
terferometry (Fig. 2A). QCM-D is an acoustic biosensing
technology that allows to monitor adsorption and desorption
Fig. 2 Bioanalytical methods to probe virus-membrane interactions. (A)
A surface-based biosensor monitors in real time the change of an acoustic
or optical signal upon adsorption of a virus particle or viral protein to
surface-deposited receptors or cell surface mimics. In such an experiment,
one of the binding partners is immobilized at the surface of a sensor chip
while the other binding partner is added using a flow chamber. The
acoustic or optical signal generated upon binding at the biosensing inter-
face can be related to the amount of material deposited at the sensor
surface. Analysis of the signal upon virus or protein adsorption together
with analysis of the detachment behavior upon rinsing yield information
on the ensemble-averaged interaction kinetics and affinity. (B) Binding of
single viruses to membranes can be efficiently probed using total internal
reflection fluorescence (TIRF) microscopy, which generates a very short-
ranged evanescent excitation field at the interface, making it possible to
visualize surface-bound fluorescently labeled viruses while discriminat-
ing them from the ones in solution. Analysis of the rate of arrival under
equilibrium conditions yields information on the association behavior of
the virus particles. Analysis of the residence time, i.e., the time spent at
the surface before detachment yields information about the dissociation
rate constant (koff). Additionally, TIRF microscopy allows for single par-
ticle tracking (SPT) which can be used to characterize the diffusive be-
havior of the surface-bound virus particles. (C) Atomic force microscopy
(AFM)-based dynamic force spectroscopy (DFS) is used to probe the
rupture forces between a virus particle bound to a sharp AFM tip and
sensor-immobilized cellular ligands, yielding histograms of the rupture
forces. Analysis of the distributions of detachment forces at different
loading rates (dynamic force spectroscopy; DFS) yields information on
the energy landscape of the interaction and on the equilibrium off-rate.
(D) Labeling strategies to probe the viral fusion process. The virus enve-
lope can be tagged with a membrane-inserting dye or a fluorescent lipid to
probe hemifusion/lipidmixing. A pH-sensitive tag can further be added to
the particle surface tomonitor the changes in pH experienced by the virus.
A fluorescent protein can be attached through genetical engineering to the
capsid, or to an accessory protein within the virus lumen to visualize
content/capsid release into the cytosol. Adapted with permission from
[45]
b
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processes at interfaces such as the binding of viruses to
receptor-presenting membranes; it provides information on
surface coverage in terms of adsorbed mass per unit surface
area as well as the hydrodynamic friction which represents
the viscoelastic and structural properties of interfacial
films [46, 47]. However, the probed mass also includes
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hydrodynamically coupled liquid, which makes absolute
quantification of mass coverage somewhat uncertain, al-
though relative variations can be quantified with high accura-
cy [47, 48]. SPR and biolayer interferometry are label-free
optical biosensing technologies that make it possible to fol-
low, in real time, the adsorption of a ligand to a receptor
immobilized on the sensor by following changes in the refrac-
tive index occurring at the interface. In contrast to QCM, the
change in the refractive index is measured with references to
the refractive index of the surrounding solution, which makes
it possible to quantify the biomolecular coverage given that
the refractive index of the biomolecule is known [49, 50]. By
analyzing the amount of ligand immobilized at the surface as a
function of the ligand concentration in solution, or by follow-
ing the adsorption and desorption kinetics at varying protein
concentrations, the affinity (Kd) is obtained. The dissociation
rate constant (koff), a measure of the bond stability, can be
quantified by recording protein detachment upon rinsing.
These methods are compatible with the use of receptor/
attachment factor-containing supported lipid bilayer (SLB)
at an interface for real-time measurements of the binding ki-
netics of viruses as function of virus concentration [51, 52].
Such data allows to extract aKd value of the overall interaction
(avidity) as well as on- and off-rates (kon and koff) by model-
ling the data using dedicated binding models. However, due to
the often very long residence times associated with multiva-
lent interactions and the notable heterogeneity within virus
populations (e.g., for pleomorphic viruses), it is generally very
difficult to relate such ensemble-averaged data (i.e., a re-
sponse which is averaged over all viruses probed) to mo-
lecular properties of the monovalent interactions (affinity).
This challenge can be efficiently tackled using methods that
probe interaction kinetics at the single particle level. In
contrast to ensemble averaging techniques, single particle
techniques are sensitive enough to extract statistics from
multiple monovalent binding events, simultaneously also
providing information about binding heterogeneity origi-
nating from multivalent interactions.
An experimental setup to study the binding of virus parti-
cles to cell-surface components on a single particle level takes
advantage of total internal reflection fluorescence (TIRF) mi-
croscopy (Fig. 2B). In this imaging method, the solute-surface
interface is illuminated using an excitation beam that hits the
interface at the critical angle of total internal reflection, creat-
ing an evanescent excitation field, the intensity of which de-
cays exponentially with the distance from the interface [53].
As typical decay lengths are in the order of 100 nm, only
fluorescently labeled objects in direct vicinity to the interface
are excited and contribute to the image generation, while par-
ticles in solution are not excited and thus not imaged by the
microscope. Using this imaging approach, the binding and
release of individual particles can be monitored under binding
equilibrium conditions, yielding quantitative information on
kon, koff, and hence Kd thanks to a data analysis procedure
referred to as equilibrium fluctuation analysis (EFA) [54,
55]. Additionally, single particle tracking (SPT) can be used
to gain information on the diffusive behavior of the receptor-
bound virus particles.
Furthermore, molecular details of the detachment behavior
of individual receptor-bound virus particles can be obtained
using dynamic force spectroscopy (DFS). For example, in
DFS experiments using atomic force microscopy (AFM),
a virus particle is immobilized at the end of a sharp AFM
tip and approached to a receptor-presenting surface (Fig.
2C). The tip is then retracted, thereby applying a con-
trolled external force which is increased over time until
unbinding (bond rupture) is observed [56]. Thus, DFS
allows, in contrast to conventional optical microscopy,
to load the virus-receptor interaction with a well-defined
external force and therefore provides information on the
stability of the interaction in dependence of the applied
force load. Interestingly, such a detachment process (and
bond failure in general) is a stochastic process, which
means that the observed detachment force often shows a
notable variation even when keeping the experimental
conditions fixed [57]. Theoretical assessments of DFS ex-
periments have shown that the mode of the corresponding
detachment force distribution (i.e., the value of the most
frequently observed detachment force) increases with in-
creasing loading rate (i.e., the rate of force increase),
which allows to gain information on the shape of the
interaction energy landscape, such as the change in free
energy associated with unbinding, the width of the bind-
ing potential, as well as the zero-force off-rate (deter-
mined by extrapolating the unbinding dynamics towards
zero force) [57].
In addition to the procedures described above to probe
virus-membrane interactions on a single particle level, a num-
ber of assays have been designed to specifically investigate
the different steps leading to virus entry by fusion, and re-
lease of the viral content/genome, on a single particle level.
In all cases, such assays rely heavily on the use of virus
particles labeled with multiple fluorophores. Often, a lipo-
philic membrane dye is included within the viral lipid mem-
brane at self-quenching concentrations [45, 58, 59],
allowing for the observation of lipid mixing and of the
hemifusion and fusion process (Fig. 2D) [45, 58, 59]. In
addition to this, a soluble fluorescent marker can be includ-
ed in the lumen of the viral particle [45, 58, 60], or the viral
capsid can be labeled directly [60–63]. Both strategies al-
low for the visualization of pore formation and viral content
release (Fig. 2D). Finally, a pH-sensitive dye may be added
to the virus particle surface, to follow endosomal acidifica-
tion and thus correlate the fusion steps with ambient pH
[60–62]. As further exemplified for the HIV-1 fusion pro-
cess, this multi-label strategy can be used in combinations
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with cell membrane mimics (in the form of liposomes [64],
giant unilamellar vesicles [63, 65], or supported lipid bilay-
ers [58, 63, 65–68]) as well as with live cells [5, 45, 69–72].
SV40 and norovirus as models to study the binding of
non-enveloped viruses to glycans
The kinetic analyses of virus binding and release are simpli-
fied if the viruses under investigation share the same well-
defined geometry. This condition is fulfilled for many non-
enveloped viruses, which are made of a highly regular capsid
and whose capsid proteins can adopt only a single or very few
geometrical configurations [73, 74]. Accordingly, first at-
tempts to acquire molecular information from the measure-
ment of virus-membrane interactions were done using either
the polyomavirus SV40 or human noroviruses. For example,
Szklarczyk et al. [42] provided a detailed picture of the inter-
action of SV40 with its receptor, the GSL GM1, by feeding
data obtained from experiments using GM1-containing sup-
ported lipid bilayers (SLBs) into a computational model of the
SV40-GM1 interaction (Fig. 1). In this case, the authors com-
bined information fromQCM-D and fluorescence microscopy
measurements to gain knowledge about the diffusion of the
GM1 GSL within the lipid membrane and the binding of
SV40 to the GM1-containing SLBs, respectively.
Interestingly, the QCM-D measurements revealed that the de-
pendence of the SV40 surface coverage on the receptor con-
centration is highly non-linear, starting with negligible SV40
binding at low GM1 concentrations (< 0.15 mol %), followed
by a steep increase in the SV40 surface coverage and a satu-
ration of the SV40 coverage after exceeding a threshold con-
centration; a similar dependency has also been observed for
norovirus [51]. Using these experimental data, the authors
were able to refine their computational model of the SV40-
GM1 interactions and to provide simulations on the time-
dependent engagement of GM1-binding sites on the SV40
capsid, as well as estimates of the valency of the membrane-
bound SV40, i.e., number of SV40-GM1 links, in dependence
of the receptor density in the planar membrane (Fig. 1). The
analysis suggested that the SV40 virus needs to bind at least 4
GM1 lipid molecules to achieve firm/irreversible attachment
to the SLBs, thereby providing a molecular picture for the
strong non-linearity observed in the SV40 surface coverage.
Additionally, the QCM-D measurements showed that once
SV40 bound to a GM1-containing SLB, the viruses remain
bound even after an extensive buffer rinse. Hence, the inter-
action appears to be basically irreversible in the absence of
external forces and accordingly, such QCM-D measurements
provide only information on the rate of SV40 attachment but
not on the detachment. In order to tackle this limitation,
Parveen et al. [75] investigated the possibility to induce
SV40 detachment by addition of a GM1 binding competitor
to SLB-bound SV40. Their study relies on cholera toxin
subunit B (CTxB) which possesses a much higher affinity to
GM1 in comparison to SV40’s VP1 (Kd << 0.1 μM vs. ~ 5
mM, respectively) [15, 76, 77], and can accordingly induce
release of membrane-bound SV40. As SV40 and CTxB differ
strongly in their liquid-related hydrodynamic friction and thus
generate different dissipation traces in QCM-D measure-
ments, it was possible to determine the individual contribu-
tions of SV40 and CTxB to the measured interface-bound
mass. This, in turn, made it possible to probe the release ki-
netics of SV40 in dependence of the binding dynamics of
CTxB. These measurements showed that a substantial amount
of GM1 receptors had to be engaged by CTxB (> 90%) before
SV40 release was triggered, indicating that CTxB is able to
bind to GM1 that were formerly bound to SV40 and thus that
depletion of GM1 (caused by engagement with CTxB) re-
duced the valency of membrane-bound SV40 until release
was induced. By solving the rate equations of CTxB binding
and SV40 release and by using estimates for the maximum
valency obtainable by SV40 on a planar membrane, it was
possible to relate the observed release kinetics with the bind-
ing strength of the single VP1-GM1 pair. In a follow-up study,
Parveen et al. [78] applied the same methodology to probe
binding of human norovirus VLPs to histo-blood group anti-
gens (HBGAs) presented on GSLs and release of these VLPs
from the HBGAs upon addition of a lectin from Ralstonia
solanacearum (Fig. 3A, B). The norovirus and the lectin bind
with different affinities to two HBGAGSLs, i.e., H type 1 and
B type 1, and thus allow to compare the impact of their dif-
ferent binding affinities to the norovirus release dynamics. In
comparison to the competitive release of SV40, norovirus
release was induced at much larger relative surface coverages
of either of the HBGA GSLs (Fig. 3A). In addition, the data
allowed to resolve that the lectin surface coverage at which the
onset of release occurred, increased with increasing HBGA
GSL concentration in the SLB. This behavior made it
possible to use the lectin surface coverage as an indicator for
the amount of binding-competent HBGAs and thus to probe
norovirus release upon subsequent reduction of the HBGA
concentration (due to engagement with the lectin). A compar-
ison of the norovirus attachment kinetics (measured for SLBs
containing different amounts of HBGA GSLs) with the so-
obtained detachment kinetics (Fig. 3B) showed that both dy-
namics were in good agreement for binding to H type 1.
However, similar comparison revealed a significant deviation
for norovirus binding to B type 1, which indicated that the
norovirus to B type 1 interaction is strong enough to increase
the HBGA GSL concentration within the virus-membrane
contact area (i.e., to induce a notable HBGA GSL accumula-
tion with respect to the remaining SLB).
These investigations indicate that receptors/attachment fac-
tors engaged in virus binding can participate in a dynamic
equilibrium with non-engagedreceptors/attachment factors
embedded in lipid membranes. The results also provided
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estimates for the strength of monovalent interactions between
the viral binding protein (VP1) and receptors/attachment fac-
tors (HBGA) embedded in a lipid membrane. This estimate,
however, relied on assumptions on the maximum valency
achievable by the virus on a planar membrane, which was
derived in these studies from geometrical considerations. In
order to relate the observed virus attachment and release rates
with molecular reaction rates, knowledge about the valency
distribution of the viruses probed is needed, which requires
methods to probe the binding and release of individual virus
particles. Such an approach was introduced by Bally et al.
[55], who linked VLPs of a norovirus GII.4 strain to an inter-
face and monitored the binding of single HBGAGSL contain-
ing, fluorescently labeled, liposomes to the viruses using
TIRF microscopy (Fig. 3C). This approach yielded informa-
tion [55] on the binding rate of liposome attachment to the
Fig. 3 Probing the binding of norovirus virus-like particles (VLPs) to
membranes using a quartz crystal microbalance with dissipation
monitoring (QCM-D; A, B) and total internal reflection fluorescence
(TIRF; C, D) microscopy. (A) QCM-D allows to probe the binding of
viruses or lectins to receptor/attachment factor-presenting membranes by
providing information on the adsorbed mass (measured in terms of a
resonance frequency f, the value of which decreases with increasingmass)
and the interfacial hydrodynamic friction (measured in terms of a dissi-
pationD, which increases with increasing friction). As the friction strong-
ly depends on the size of the adsorbed object, it is possible to distinguish
binding events caused by viruses and proteins and thus to probe the
release of membrane-bound viruses upon addition of a binding compet-
itor having a higher affinity to the receptor/attachment factor (e.g., a
lectin). This provides information on the binding strength of the virus-
membrane interaction and (B) on the accumulation of receptors/
attachment factors by the virus, which generates deviations between the
relative virus surface coverage, determined during the initial binding pro-
cess (B, solid line) or lectin-induced virus release (B, circles) [78]. (C)
TIRFmicroscopy can be used to probe the binding of receptor/attachment
factor-containing, dye-labeled vesicles and interface-linked viruses,
allowing to determine the impact of the constituents (e.g., vesicle com-
position or virus strain) on the overall interaction. (D) This approach was
used to probe the interaction of individual norovirus particles to lipid
membranes obtained from lipids extracted from human intestinal
enteroids established from various individuals. Thanks to such an exper-
iment, the attachment rates (slopes in D, left) as well as the off-rates
(decay of residence time, D right) of virus-membrane interactions can
be related to the patterns of susceptibility to infection for various individ-
uals [23, 55]. Adapted figures with permission from [23, 55, 78];
Copyright by the American Chemical Society and American Physical
Society, respectively
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norovirus VLPs as well as the distribution of the liposome
residence time on the VLPs using the EFA data analysis meth-
od (Fig. 3C, D). The single virus particle resolution provided
by TIRF microscopy imaging allowed the identification of
subtle variations in the binding to H type 1 and Lewis b
HBGAs, such differences that were hidden in conventional
ensemble-averaged measurements. Furthermore, information
on the rate of bond breakage (off-rate, koff) should be extract-
able from the measured residence time distributions, which
was demonstrated in interaction studies of fixed valency.
The corresponding distributions obtained from the
norovirus-HBGA interactions were, however, too broad to
allow for the extraction of molecular off-rates, which was
attributed to a notable variation of the binding valency within
the ensemble (caused by a notable variation in size of the
liposomes and possibly also in their HBGA content). A sim-
ilar experimental approach was used recently by Rimkute
et al. [23] to probe the interaction kinetics between another
GII.4 norovirus VLP and HBGA-containing vesicles, pro-
duced from lipids extracted from human intestinal enteroids.
Here, the enteroids were established from biopsies of six in-
dividuals exhibiting distinct histo-blood group antigen pro-
files and varied in susceptibility to norovirus infection (Fig.
3D). This experimental approach made it possible to relate
virus-membrane interaction kinetics to susceptibility patterns
and to pinpoint kinetic features which may be of relevance in
this context.
Studies of fluorescently labeled norovirus VLPs have re-
vealed that the VLPs cluster on supported lipid bilayers con-
taining GSLs [79]. Larger clusters were observed on bilayers
containing GSLs with a higher affinity for the VLP. It was
hypothesized that the clustering was promoted by virus-
induced membrane deformation. Indeed, norovirus VLPs
have been shown to induce membrane invaginations upon
binding to GSL incorporated into giant unilamellar vesicles
[80] in a similar manner as SV40 [14]. For the latter virus, it
has been proposed that such invaginations lead to the forma-
tion of vesicles that transport the viruses through the
cytoplasm.
As the valency has a strong impact on the virus residence
time [7], information on the valency and the residence time of
the viruses is needed to extract the (valency-dependent) off-
rate. Such information can, in principle, be obtained if the
virus binds to receptors/attachment factors which are able to
diffuse within a (fluid-phase) SLB. Indeed, complexation of
SLB-embedded structures (e.g., lipids or membrane proteins)
has been shown theoretically and experimentally, to reduce
the diffusion coefficient of the complexes in the lipid bilayer
[42, 81, 82]. In general, the diffusion coefficient of the com-
plex (virus bound on a planar lipid membrane) decreases mo-
notonously with increasing number of ligand-receptor pairs
[83]. This allows us, in principle, to gain information on the
valency of a SLB-bound virus by determining the lateral
diffusion coefficient of single virus particles. Application of
SPT to SLB-bound SV40 indeed showed a transition from full
immobilization (no measurable diffusion) to random motion
and release of SV40 upon addition of CTxB. This observation
indicates that receptor depletion continuously lowered the
SV40 valency causing virus mobility and finally virus release
[75]. Nevertheless, the interaction between SV40 and GM1,
as well as norovirus and H type 1 and B type 1 GSLs, is so
strong that these viruses remain essentially immobile without
addition of a binding competitor [75, 79], which has so far
hindered the application of this methodology to extract the
exact (valency-dependent)off-rate distributions.
Influenza virus as a model for describing single
particle interactions with sialic acids
The influenza A virus (IAV) which relies on sialic acids for
attachment and entry into the host cell has been extensively
used to initially demonstrate how off-rates of single viruses
interacting with membranes can be extracted [84, 85]. Indeed,
due to its huge relevance for the public health, IAV has be-
come an important model virus in bio(physico)chemical in-
vestigations relying on methods such as SPR [86], NMR [40],
X-ray diffractometry [87], biolayer interferometry [88], gly-
can arrays [89, 90], as well as various microscopic techniques
[84, 85, 91]. In particular, both dynamic force spectroscopy
(DFS) and optical microscopy have been used to probe virus-
receptor interaction at different complexities in terms of the
macromolecules involved in the experiment. Indeed, the inter-
action partners investigated with DFS range all the way from
the use of truncated versions of viral proteins and receptors
immobilized at defined interfaces [92], up to entire viruses
interacting with the plasma membranes of host cells [84].
The first demonstration of probing the binding strength of
intact influenza viruses by force spectroscopy was done by
Sieben et al. [84], who employed optical tweezers and
AFM-based DFS to determine the force needed to detach
IAVs (strains X31 and WSN/32) [56, 84] from the surface
of live host cells [57, 84] (Fig. 4A, B). Single unbinding
events, which showed detachment forces in the order of 10–
20 pN (for loading rates ranging between 10 and 1000 pN/s)
were observed most of the time (Fig. 4A) and were attributed
to unbinding of single IAV hemagglutinins from sialylated
structures presented on the cell surfaces. Surprisingly, only
little variation in unbinding was observed using the different
IAV strains and three different cell lines (Fig. 4B). As the
virus strains used are known to differ in their binding prefer-
ence to sialic acids (α2,3-linkage for WSN/32 and α2,6-link-
age for X31) and as MDCK and A549 cells clearly express
sialic acids with α2,6-linkage but CHO cells present only
sialic acids with α2,3-linkages [89], this finding suggests that,
on a molecular level, the hemagglutinins bind with
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comparable affinity to sialic acids in both α2,3- and in α2,6-
linkages. This observation is in agreement with NMR mea-
surements of binding affinity as well as with glycan array
experiments, showing that a multivalent presentation of at-
tachment factors can strongly enhance the preference for a
particular linkage [40, 94]. Recent measurements show that
both hemagglutinins and neuraminidases of IAVs are able to
bind to sialic acids with comparable binding strengths, sug-
gesting that both surface proteins of IAVs are involved in the
cell-surface attachment of the virus [92]. This observation
indicates that the role of neuraminidase in the IAV binding
and unbinding process ranges well beyond the promotion of
IAV egress through sialic acid cleavage activity. Hence,
gaining more insights into the complex interplay of hemag-
glutinins and neuraminidases during IAV binding and unbind-
ing requires probing these processes at equilibrium. The first
measurement of the IAV binding and unbinding at equilibri-
umwas done by Lee et al. [91], who used TIRF microscopy to
monitor the transient attachment of the IAV strain X31 to
SLBs containing sialic acid–presenting lipids (analogous to
Fig. 2B). Application of the EFA method made it possible to
determine how the lipid structure, i.e., the presentation of
Fig. 4 Probing the interaction of influenza A viruses (IAVs) with cells
and attachment factors using dynamic force spectroscopy (DFS; A, B)
and TIRF microscopy (C, D). (A) AFM-based DFS applied to the inter-
action of IAVs with cells showed mostly single rupture events, which are
attributed to the unbinding of single viral proteins from sialylated struc-
tures on the cell’s plasma membrane. (B) The loading rate–dependent
unbinding force showed only little variation across the different IAV
strains and cell lines used, which is in line with previous studies showing
only minor differences in the affinity to IAV’s protein hemagglutinin to
α2,3- and α2,6-linked sialic acids [84]. Adapted figure with permission
from (Sieben 2012); Copyright by the National Academy of Sciences. (C)
TIRF microscopy applied to dye-labeled IAVs interacting with sialic
acid–presenting supported lipid bilayers (SLBs) showed that due to the
fluid nature of themembrane, IAVs canmove laterally while being bound
to the membrane (C, left). The speed of this process (quantified in terms
of a diffusion coefficient) contains information on the number of attach-
ment factors engaged by the IAV, which can be used to determine the
relationship between IAV residence time and number of bound attach-
ment factors and to monitor how this relationship is modified by neur-
aminidase inhibitors (C, right). Furthermore, bymonitoring the frequency
of virus binding to the interface, the assay also provides information on
the rate of virus attachment (D). Addition of substances that inhibit virus
binding (by either blocking the viral proteins or the attachment factors)
causes the virus attachment rate to decrease with increasing inhibitor
concentrations, which can be quantified using the assay and used to assess
the performance of virus binding inhibitors [85, 93]. Reprinted figures
with permission from [85, 93]; Copyright by the American Chemical
Society and Wiley-VCH, respectively
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sialic acids by the lipids, modified the rate of IAV attachment.
Similar to previous studies using norovirus [55], the measure-
ments yielded very broad residence time distributions, which
did not allow to extract off-rates of the interaction. This prob-
lemwas approached byMüller et al. [85], who took advantage
of the fact that lipids within fluid-phase SLBs are able to move
laterally with a diffusion coefficient for the 2D diffusion of the
sialic acid–bound IAV (Fig. 4C) indicative of the number of
lipids bound by the tracked IAV [83]. This characteristic was
used [85] to extract valency-dependent residence time distri-
butions and thus to determine the IAV off-rate in dependence
of a measure for the average number of bound attachment
factors (Fig. 4C). Interestingly, the off-rate showed the expect-
ed decrease for increasing valency (caused by the fact that a
higher valency requires more single interactions to be broken),
but also an unexpected peak behavior, demonstrating that the
off-rate increased above the expected values for certain bind-
ing valences. Application of the neuraminidase inhibitor
zanamivir caused this peak to disappear, showing that this
peculiar feature in the valency-dependent off-rate is caused
by a competition in the opposing activities of the hemaggluti-
nin and the neuraminidase. In a related study [93], the same
assay was used to probe the decrease in IAV attachment rate
caused by interaction with sialic acid–presenting polymers
(Fig. 4D). Such polymer-based virus binding inhibitors are
designed to bind specifically to IAVs by the hemagglutinin-
sialic acid interaction and are therefore expected to inhibit
IAV binding to sialic acid–presenting(cell) membranes.
Application of the TIRF-based binding assay revealed a com-
plex dependence of inhibitor concentration on the IAV attach-
ment rate, which showed a biphasic behavior instead of the
expected monotonous decrease and was attributed to an inter-
action of the sialylated compoundwith both proteins, the hem-
agglutinin and the neuraminidase (Fig. 4D). Furthermore, the
assay enabled to probe changes in the multivalent interaction
caused by addition of the virus binding inhibitors, which can
be used to assess their inhibition efficiency.
These examples show that both methods, DFS and equi-
librium binding probed using TIRF microscopy, are very
powerful approaches for characterizing complex interac-
tions on a molecular level. Due to their single-virus/single-
molecule resolution, both techniques are able to extract in-
formation and identify subpopulations, which are typically
lost in the ensemble-averaging process of traditional bind-
ing assays. This high resolution requires, however, more
sophisticated and time-consuming data analysis schemes,
which represents a notable bottleneck in inhibitor screening
applications. Hence, ensemble-averaging and single-
molecule binding assays complement each other in this re-
spect, as their combinations enable an initial screening of
many compounds, followed by an investigation on the bind-
ing properties of the most successful candidates using
single-molecule binding assays.
Herpesviruses as a model of glycosaminoglycan-
binding viruses
Together with sialic acid moieties, sulfated glycosaminogly-
cans (GAGs) are the most common attachment factors for
viruses and accordingly, a large variety of human viruses take
advantage of these carbohydrates for their initial recruitment
to the surface of host cells [8], including the human papillo-
mavirus, filovirus, flavivirus, coronavirus families, and her-
pesviruses HSV-1 and HSV-2 [95]. GAGs are linear polysac-
charide molecules consisting of repeating disaccharide units.
They are major constituents of the glycocalyx, extending up to
several 100 nm above the plasma membrane [96]. While the
molecular players involved in virus-GAG recognition are of-
ten known, little attention has been devoted to the dynamics of
such interactions. Indeed, it remains essentially unknown how
the interactions are modulated to facilitate viral infection and
to confer optimal attachment, detachment, and diffusion be-
havior to the virus at the cell surface.
In an attempt to elucidate the mechanisms regulating virus-
GAG interactions at the cell surface, minimal models of the
cellular glycocalyx have been implemented. These typically
consist of isolatedGAGs, immobilized on a sensor surface in a
biomimetic fashion [97–102]. For example, the immobiliza-
tion of GAG chains in an end-on fashion via their reducing
ends (Fig. 5A) mimics the presentation of the carbohydrates
on the core proteins of proteoglycans. The advantage of such a
bioanalytical platform is that it can be used to systematically
investigate how the physicochemical properties of the GAG
adlayers, including GAG type, chain length, degree of
sulfation, and chain density, influence the characteristics of
the interactions of viruses in the glycocalyx. Such a platform
has been extensively implemented, for example, in the context
of studying, on a molecular level, how attachment, detach-
ment, and diffusion of HSVs are regulated at the cell surface
[97, 98, 100, 103]. Specifically, the modulatory roles of the
viral mucin-like region, a cluster of O-linked glycans, found
on viral glycoprotein gC of HSV-1, and of the cellular GAGs
have been explored. In a reductionist approach, the binding
activity of isolated gC proteins to sensor-immobilized CS
chains was investigated using a SPR-based binding assay
[97]. A comparison of the binding behavior of wild-type gC-
1 (gC-WT) and mucin-deleted gC-1 (gC-Δmuc) revealed that
the apparent affinity of the mutant was significantly lower
than that of the wild type, in spite of the fact that its dissoci-
ation was drastically slower. This indicated that gC-Δmuc
attached less efficiently to the GAGs as compared to the
wild-type gC protein, but that once formed, the gC-Δmuc-
CS complex was more stable. Importantly, this result is in line
with observations on the cellular level, which revealed that the
mucin-deleted mutant virus is less sensitive to inhibition
through GAG mimetics [97, 104], while having a reduced
ability to detach from the surface of infected cells [97]. In
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addition to this, gC-WT was found to bind with similar affin-
ity to CS and to an artificially sulfated GAG, sulfated
hyaluronic acid (sHA), in spite of the lower sulfation density
of the former. This suggests that binding is not merely medi-
ated by electrostatic interaction with the negatively charged
sulfates but that a certain degree of specificity is provided by
the enzymatically sulfated native GAG, as compared to the
artificial one, which is sulfated chemically in a random fash-
ion [97]. These observations on the gC protein level were
further corroborated by studying the binding behavior of in-
dividual virus particles in the GAG mimetic platform using
TIRF microscopy. These studies further confirmed that viral
particles with gC mutants, lacking the mucin-like region
(HSV-1-gC-Δmuc), associate less efficiently to the carbohy-
drates than the HSV-1-WT [97]. Further molecular details of
the detachment behavior of individual GAG-bound virus par-
ticles were obtained using AFM-based DFS (Fig. 5B). Such
experiments performed with HSV-1-WT and HSV-1-
gC-Δmuc revealed that deletion of the mucin-like region cor-
related with a ~ 6-fold decrease in koff [98], once again in line
with observations on the protein level [97]. Further data anal-
ysis also suggested that the mucin-like region modulates the
Fig. 5 Probing HSV-glycosaminoglycan (GAG) interactions using
surface-immobilized GAGs. (A) A biomimetic GAG-platform based on
the end-on immobilization of GAGs via biotin-streptavidin is used to
probe the interaction between GAGs and viral glycoproteins or viruses.
(B) Dynamic force spectroscopy (DFS) experiments are used to probe the
virus-GAG binding strength. The histograms, showing the rupture force
frequency recorded between CS and HSV-1-WT, are fitted with multiple
Gaussian curves for different ligand-receptor interactions (top) and then
compared for HSV-1-WT and HSV-1-gC-Δmuc (bottom). Black-shaded
areas show higher binding frequencies for HSV-1-WT, while the gray-
shaded areas correspond to higher binding frequencies for HSV-1-gC-
Δmuc. The overall higher binding force for the mutant virus translates
into a smaller koff (reproduced with permission from [98]). (C) Single
particle tracking (SPT) with total internal reflection fluorescence (TIRF)
microscopy is used to determine the diffusion coefficient of individual
GAG-binding viruses. (i) The distribution of the diffusion coefficient is
broad, spanning over several orders of magnitudes. (ii) Studies of the
diffusion behavior (anomalous diffusion) of HSV-1 on different types
of GAGs reveal that the diffusion coefficient depends on the type of
GAG it is bound to (sHA, sulfated hyaluronic acid; CS, chondroitin
sulfate; HS, heparan sulfate) (reproduced with permission from [100]).
(D) Probing HSV-1 binding using native supported lipid bilayers
(nSLBs). (i) To produce native supported lipid bilayers (nSLB), the cell
is mechanically lysed and native membrane vesicles are isolated. These
are then converted into hybrid vesicles via a sonication procedure in the
presence of liposomes. The hybrid vesicles spontaneously form a nSLB
on glass. The nSLBs were then used to probe the influence of HS on
HSV-1 binding. Removal of HS through heparinase III treatment leads to
(ii) a reduction in association rate constant (kon) and (iii) an increase in the
dissociation rate constant (koff). Blue, untreated; red, heparinase treated;
black, negative control. Reproduced with permission from [106, 101]
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interaction by regulating the affinity, type, and number of
glycoproteins involved in virus-GAG interactions [98], most
likely by initially shielding other viral glycoproteins,
preventing them from engaging prematurely in an interaction
with cell-surface receptors. Such a shielding effect has also
been reported for other herpesviruses, such as the murine her-
pesvirus (MHV-4), where the heavily O-glycosylated gly-
coprotein gp150 was found to negatively regulate virus at-
tachment to GAGs by reducing the number of contacts ini-
tially formed with GAGs, as revealed by AFM-based DFS
performed with GAG-presenting surfaces. This observation
was further confirmed by similar experiments on live cells,
where the gp150-negative virus mutant was found to adhere
with increased frequency to GAG-positive cells but not to
GAG-negative ones [99]. In a different study, the diffusive
behavior of GAG-bound viruses was investigated. Single
particle tracking of GAG-bound HSV-1 particles using
TIRF microscopy revealed that GAG-bound viruses have
the capability of diffusing laterally on predominantly im-
mobile GAG chains (Fig. 5C), presumably through a hop-
ping or rolling behavior resulting from a molecular ex-
change mechanism where the formation and dissolution of
individual bonds between viral glycoproteins and neighbor-
ing cellular GAGs allow for a lateral motion [100]. These
results suggest that GAG-binding viruses such as HSV may
take advantage of relatively weak interactions with GAGs
to diffuse through the glycocalyx and along the cell surface,
to reach the appropriate entry receptor. This hypothesis was
recently further supported by observations on the cellular
level (Bally et al. unpublished).
So far, we have illustrated how minimal cell surface
mimics can be used to study virus-GAG interactions, with
the example of HSV-1. In such a reductionist approach, only
the molecules of interest (GAGs) are taken into consider-
ation, allowing for systematic investigations of how select-
ed components contribute to the overall virus membrane
interactions. However, in some cases, a bioanalytical plat-
form presenting the complete repertoire of the plasma mem-
brane components, including lipids, carbohydrates, and
proteins, in a native-like environment may be desirable.
The use of such a platform may be beneficial for applica-
tions requiring a better understanding of the way the virus
interacts with the membrane as a whole, i.e., with all recep-
tors, co-receptors, and adhesion factors, both known and
unknown. This may be useful for example in the context
of efficiently screening for virus binding inhibitors.
Additionally, a platform generated from cellular membrane
extracts facilitates the study of membrane components dif-
ficult to isolate and purify. Along these lines, a number of
research groups have proposed approaches to deposit
native-membrane material purified from cells at a sensor
surface, in the form of supported lipid bilayers of complex
composition, i.e., native supported lipid bilayers (nSLBs).
The advantage of such nSLB platforms is that they display
the full compositional complexity of the cell surface, at a
given time, but are decoupled from the physiological pro-
cesses present in live cells. Accordingly, nSLBs have been
implemented to virus research [58, 59, 101, 105], illustrating
how they can be used to decouple the contribution of individ-
ual cell membrane components from the ones of other cellular
factors, when studying virus-membrane interactions. The ap-
proach, originally presented by Pace at al. [106, 107] to pro-
duce compositionally complex nSLBs (Fig. 5D(i)), has recent-
ly been implemented to herpesvirus research [101]. Here,
nSLBs were produced by lysing a cell of interest and harvest-
ing plasma membrane material in the form of native mem-
brane vesicles. These native membrane vesicles were then
combined with synthetic lipids through sonication, yielding
hybrid vesicles containing the original components of the cell
but also increased amounts of phosphatidylcholine and
pegylated lipids. These hybrid vesicles readily fuse into a
supported lipid bilayer with preserved transmembrane protein
fluidity [106] (Fig. 5D(i)). Using this nSLB platform and
TIRF microscopy to visualize individual HSV-1 virus bind-
ing, it was reported that heparinase treatment leads to a de-
crease in the virus particle association rate and an increase in
the dissociation rate by a factor of 1.6 and 2.5, respectively
(Fig. 5D(ii and iii)), making this interaction more mobile. This
analytical approach therefore provides quantitative insights
into how heparan sulfate influences virus binding, release,
and diffusion at the cell surface.
Taken together, this section illustrates the potential of
working with bioanalytical platforms relying on cell surface
mimics in constant feedback with in vitro cell-based assays to
gain a mechanistic understanding, on the molecular level, of
how cellular processes are regulated in live cells. It demon-
strates how an experimental approach relying on combining
various levels of molecular complexity can lead to drastically
new insights into cell biology and virology.
HIV as a model system to study protein receptor
binding, fusion, and cellular entry
Currently, there is still an open debate on the relative impor-
tance of HIV-1 entry via fusion at the plasma membrane or
fusion in the endosomes, and more importantly, about which
pathways that lead to productive viral replication in the target
cells. This controversy brings up fundamental questions about
the individual and/or synergistic roles of the three major fac-
tors likely to influence HIV-1 fusion, i.e., interactions with
receptors/co-receptors, lipid membrane factors (composition,
domains, curvature, diffusion, etc.), and pH conditions within
the endosomes.
Cell membranemimics of increasing complexity have been
used by the Tamm group to elucidate the mechanisms by
which nanometer-sized domains rich in cholesterol and
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sphingomyelin facilitate fusion of HIV-1 with cellular mem-
branes. Such investigations were motivated by reports indicat-
ing that the receptor and co-receptor for HIV-1 infection are
preferentially enriched in lipid domains [108], implying that
those domains are the sites of membrane fusion. This may
however appear energetically unfavorable at first glance, since
the rigidity and tighter lipid packing of cholesterol-rich do-
mains may hinder membrane rupturing or fusion. To assess
this issue and quantify energy barriers, studies were carried
out on compositionally simple cell membrane mimics [63,
65]. These consisted of lipid-only membranes containing
liquid-order(Lo) domains, mimicking the lipid composition
of the plasma membrane of the target cells. This reductionist
approach revealed that both the fusion peptide on HIV-1 gp41
and pseudotype HIV-1 particles interact predominantly at Lo/
Ld(liquid-disordered) phase boundaries. Membrane fusion
was also found to occur preferentially (~ 70%) in those areas,
suggesting that the edges of lipid domains are the preferred
sites of fusion and may thus play a key role as a site of HIV-1
entry [63]. Further investigations using various lipid compo-
sitions, as well as compounds reducing the line tension at Lo/
Ld boundaries (linactants), reveal that reduction of line ten-
sion at the domain boundaries is a major energetic driver for
HIV-1 fusion, and possibly entry [65].
Mechanistic studies of binding and fusion of HIV using
reconstituted in vitro systems are complicated by the fact that
the process requires two essential cellular transmembrane pro-
teins: the receptor CD4 and a co-receptor, either CCR5 or
CXCR4. To include receptors and co-receptors in their
bioanalytical assays, the Tamm group used giant unilamellar
vesicles and planar supported membranes derived directly
from the plasma membranes of cells expressing CD4 and
CCR5 [58, 59]. Giant plasma membrane vesicles (GPMVs)
were obtained by gently treating the cells with formaldehyde
and dithiothreitol, leading to the formation of membrane blebs
(Fig. 6A). These blebs were converted into supported planar
plasma membranes (SPPM) by fusing the GPMVs onto poly-
mer supported lipid monolayers at an elevated temperature
(>37°C). This resulted in a planar membrane geometry which
facilitated the recording of single fusion events over large
surface areas by TIRF microscopy (Fig. 6C). It also allowed
for classification of the fusion events into hemifusion or com-
plete fusion. Importantly, upon cooling to room temperature,
these structures were found to exhibit large scale (μm size)
phase separation, facilitating the study of processes occurring
in lipid domains and at their boundaries. Immunofluorescence
staining of receptor and co-receptor confirmed that CD4 co-
localizes within the Lo phase, while the co-receptor CCR5
was distributed at the Lo/Ld phase boundaries. Moreover, in
agreement with observations on the lipid-only systems,
receptor-bound HIV-1 pseudotypes preferentially localized
at the Lo/Ld boundary. Fusion also occurred at such
boundaries. Furthermore, the presence of these boundaries
was a prerequisite for successful fusion, as verified by
disrupting the Lo domains by cyclodextrin treatment to re-
move cholesterol or using lysolipids to dissolve the microdo-
mains [59]. Besides providing quantitative information on the
fusion behavior of HIV pseudotypes on CD4+/CCR5+ mem-
branes [59], such SPPMs were used to gain detailed mecha-
nistic insights into the antiviral mode of action of the host
restriction factors Serincs and their influence on the different
steps of HIV-1 fusion [58].
While the bioanalytical platforms presented above allowed
the examination of virus-membrane interactions at the single
virus level and contributed to reveal the molecular mechanism
of HIV fusion, they can neither be applied to evaluate the
statistical distribution of different fusion or entry pathways
nor to comment on whether they lead to cell infection. This
can only be achieved by imaging infected cells and by visual-
izing the binding and entry of individual virus particles in a
time-dependent manner and with a high spatial resolution. In
the last two decades, a number of research groups have
established single virus imaging conditions to study early and
late stages of virus replication [4, 109–113]. Fluorescence im-
aging of HIV-1 attachment and fusion on a single particle level
was extensively carried out recently by the Melikyan group
[45, 111, 113] who established multi-color fluorescence imag-
ing of single viruses to distinguish between plasma membrane
fusion and endosomal fusion, and to evaluate the statistical
distribution of the different fusion pathways. Moreover, they
connected these fusion events to successful viral cell infection.
Miyuachi K. et al. [45, 61] revealed three populations of HIV
viruses. The first type of virus particles is relatively static at the
plasma membrane and experiences early hemifusion but no
release of the viral content. The other two types of virus parti-
cles are endocytosed and become mobile with or without di-
rectional transport towards the nucleus. Endosomal fusion was
correlated with successful infection, using virus pseudotypes
carrying a reporter gene. Furthermore, Miyuachi K. et al. [61]
and Sood C. et al. [60] used a pH-sensitive tag at the virus
surface to confirm that HIV-1 particles only release the viral
content after entering acidic endosomes, and not at the plasma
membrane. A similar imaging approach with quantitative eval-
uation showed that fusion of retrovirus homologues to HIV-1
also occurs in early or late endosomes [62]. The viral capsid,
either intact or partially intact, was slowly released into the
cytosol but only after the endosomal fusion, as confirmed upon
imaging of dual-color labeled HIV-1 particles [60, 114]. In
conclusion, the work by the Melikyan group illustrates that
such co-localization imaging in a time-dependent manner is a
reliable approach to analyze the statistical distribution of mem-
brane fusion events and to follow the time evolution of the pre-
to post-fusion process leading to release and replication of the
viral genome.
Bally M. et al.
Conclusions and future perspective
Using several examples of well-characterized enveloped and
non-enveloped viruses, this review highlights the nature of the
information obtainable through implementation of emerging
bioanalytical tools to study virus-membrane interactions. It
illustrates the potential of such approaches in the context of
studying viral binding kinetics, diffusivity, and fusion at the
cell membrane, while emphasizing the importance of
multivalency in virus binding and uptake.
The appearance of SARS-CoV-2, and the current global
pandemic, has reminded us all of the importance of develop-
ing new vaccination platforms against viral diseases together
with powerful antiviral drugs. In this context, it is our hope to
have demonstrated that, beyond providing insights into the
molecular mechanisms underpinning viral infection, emerg-
ing bioanalytical techniques also represent a solid foundation
to the development of antivirals interfering with complex cel-
lular entry pathways. This is exemplified in this review by the
capacity to pinpoint how the neuraminidase inhibitor
zanamivir affects IAV attachment, as well as the possibility
to quantify the extent to which host molecules must be
blocked before release of attached virus particles is initiated.
A variety of antiviral strategies targeting different aspects
of interactions between viruses and cell membranes have al-








Fig. 6 HIV-1 binding and fusion events observed using confocal
fluorescence and TIRF microscopy. (A) Scheme showing cell membrane
derived giant plasma membrane vesicle (GPMV) formation with lipid
ordered (Lo=red) and disordered (Ld=blue) phases and HIV-1 binding
preferentially to the Lo/Ld boundaries. (Ai) Number of HIV-1 particles
bound to Lo, Ld, and Lo/Ld. Corresponding representative confocal im-
ages are shown and described in panels below. (Aii) The bright-field
image shows GPMVs formed and attached to cells. (B) Confocal micro-
graphs of GPMVs depict how, at higher resolution of selected rectangle,
CD4 (immunolabeled) distributes into Lo phase, separated fromDil stain-
ing (lipid anchoring dye, known to distribute into the Ld phase). (C)
Fluorescent micrographs showing the distribution of HIV-1 (labeled
green with mKO-Gag) at the single particle level binding to the Lo phase
and possibly to Lo/Ld boundaries but less to the Ld phase (labeled with
DiO). (D) Scheme of formation of a supported planar plasma membrane
(SPPM) and its application for dynamic imaging of HIV-1 binding and
fusion using TIRF microscopy. (E) TIRF micrographs showing how dif-
ferently CD4 distributes into the Lo phase while CCR5 tends to distribute
at Lo/Ld boundaries and in Ld phase. (F) TIRF images illustrating how
(mKO-Gag) labeled HIV-1 particles bind to the SPPM (Ld phases labeled
with Dil). It appears that the virus tends to bind in the Lo phase (green
spots) and fuses at the Lo/Ld boundaries (diffused green signal). Time-
lapse TIRF images were further analyzed to determine the percentage of
HIV-1 binding, hemifusion, and fusion events in Lo, Ld, and Lo/d bound-
aries of the SPPM. Reproduced with permission from [59]
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Examples include the HIV drugs maraviroc and fostemsavir
which target a cellular co-receptor and a viral adhesion pro-
tein, respectively [114–116]; docosanol which has been sug-
gested to act on HSV binding [114]; and the influenza drug
DAS181which prevents virus attachment through its sialidase
activity [117]. Additionally, monoclonal antibodies, such as
the ones against SARS-CoV-2, which have recently gained
emergency authorization in several countries [118], are also
a promising class of binding inhibitors, likely to see their
implementation drastically increase in the coming years
[114]. The techniques described in this review have the po-
tential to provide further mechanistic insights into the mode of
action of such antivirals. Thereby, they will likely contribute
both to refining existing antiviral strategies and to proposing
radically new approaches for targeted treatments.
The current bottleneck to the widespread implementation
of the emerging bioanalytical methods described here is that
they require advanced instrumentation which is not yet suit-
able for high-throughput screening. However, optical micros-
copy in particular is at present witnessing tremendous devel-
opmental gains making it very likely that many approaches
discussed in this review will soon become broadly available
even in the biosafety level 3 and 4 laboratories required to
work with highly pathogenic viruses.
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